Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1Phase 3 1

Status

Recruiting 3Completed 3

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 4

Conditions

Leukemia, Myeloid, Acute 76Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia 36Lymphoma 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 8Leukemia, Myelomonocytic, Acute 7Leukemia, Megakaryoblastic, Acute 7Burkitt Lymphoma 7Neoplasm, Residual 6Myelodysplastic Syndromes 6Congenital Abnormalities 6Leukemia, Biphenotypic, Acute 4Recurrence 3Leukemia, Promyelocytic, Acute 3Anemia, Refractory, with Excess of Blasts 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Philadelphia Chromosome 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Down Syndrome 2Dendritic Cell Sarcoma, Interdigitating 2Thrombocytopenia 1Sarcoma 1

Interventions

Cyclophosphamide 21Cytarabine 15blinatumomab 13fludarabine 12Azacitidine 10venetoclax 9fludarabine phosphate 9Blood Specimen Collection 8Methotrexate 7Lenalidomide 7Dexamethasone 7Rituximab 6Mercaptopurine 6Daunorubicin 6Vincristine 5daratumumab 4Whole-Body Irradiation 4Melphalan 4Etoposide 4Busulfan 4obinutuzumab 3Radiotherapy 3Neoadjuvant Therapy 3Maintenance 3Liquid Biopsy 3Immunotherapy, Adoptive 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Neoplasm, Residual × Daunorubicin × Clear all
NCT07131059 2025-08-20

MRD-positive AML Clinical Study

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
120 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT05959720 2025-05-07

BRALLA

Instituto do Cancer do Estado de São Paulo

Recruiting
180 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02724163 2021-10-08

Myechild01

University of Birmingham

Phase 3 Recruiting
700 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡